Validation for the biotechnology industry is substantially different from that of traditional pharmaceutical manufacturing, because of the complexity and inherent uncertainty of using living organisms as production systems to manufacture complex, biologically active proteins. Uncontrolled and untested changes in the manufacturing process, including both known and unknown raw materials, can impact the activity and antigenicity of the protein by inducing subtle changes in its structure or conformation. Therefore, controlling the manufacturing process using well-defined operating parameters and raw materials is critical to assuring the safety, potency and consistency of the product. Process validation provides a critical mechanism for understanding and controlling these vital manufacturing parameters.
This course provides an overview of the validation effort as applied to clinical and commercial biotechology manufacturing. Topics include the general approach to validation; a review of important biotechnology manufacturing processes, and the strategies and requirements for their validation. Specific topics include validation of buffer/media preparation systems, upstream processes such as fermentation and cell culture, and downstream processes such as centrugation, filtration, and chromatography. Other topics include: master plan development and execution, cleaning validation, analytical methods requirements, protocol writing and execution, and handling of deviations.
In addition to the classroom lecture, participants will take part in several interactive exercises and discussions that allow application of learned content to a typical biotechnology manufacturing process. Participants should have a basic understanding of commissioning, qualification and validation, and also at least a basic familiarity with biotechnology manufacturing processes and unit operations.